from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0743c/-

LFCtreatmentdescriptionclass of inhibitor

2.773

Amikacinug/mL Amikacintranslation

1.696

Cap5-10ug/mL Capreomycintranslation

2.804

Rox10-50 ug/mL Roxithromycintranslation

1.459

SM2-5 ug/mL Streptomycintranslation

0.689

Tet5-10 ug/mL Tetracyclinetranslation

0.991

Rif0.2-5ug/mL Rifampicintranscription

0.210

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.797

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.879

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.551

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.251

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.421

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.193

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.134

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.556

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.010

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.919

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.649

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.843

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.295

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.312

KCN5-20 ug/mL Potassium cyaniderespiration

0.106

NaN30.2-2 mM Sodium aziderespiration

0.289

Nigericin50 uM Nigericinrespiration

0.573

TRC10-150 ug/mL Triclosanrespiration

0.900

TRZ10-25 ug/mL Thioridazinerespiration

0.688

Valinomycin0.5-10 uM Valinomycinrespiration

-0.229

ZnSO42 mM ZnSO4respiration

0.453

menadione6-10 ug/mL Menadionerespiration

0.125

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.266

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.009

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.176

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.732

NRP_1Non-replicating persistence stage 1dosRassociated

-0.730

Amp0.2mg/mL AmpicillincellWall

-0.106

Cephalexin20-100 ug/mL CephalexincellWall

0.747

Cerulenin0.32-5 ug/mL CerulenincellWall

0.182

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.227

EMB10-20 ug/mL EthambutolcellWall

-0.280

Eta12-40 ug/mL EthionamidecellWall

-0.800

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.445

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.016

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.611

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.117

BZA0.12 mg/mL BenzamidearomaticAmides

-0.149

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.223

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.179

H2O24 mM hydrogen peroxideDNAdamaging

-0.137

Levo10 ug/mL LevofloxacinDNAdamaging

-0.309

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.455

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.457

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.726

UVUV-irradiationDNAdamaging

0.013

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.316

Antimycin12.5-50 ug/mL Antimycin A?

0.646

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.149

PA_110-50 ug/mL Antitubercular compound PA-1?

0.204

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.006

PA8240.2-2 ug/mL PA-824?

-0.629

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.452

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.163

Verapamil50 uM Verapamil?

-0.404

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.167

methoxatin10-20 ug/mL Methoxatin?